Novo Nordisk A/S (CPH: NOVO-B) is being punished this morning after posting a disappointing update related to CagriSema. The pharmaceutical behemoth said its experimental weight-loss treatment helped patients lower their weight by 22.7% in a late-stage trial – lower than 25% it had originally expected. Novo Nordisk stock was down…
Shares of Humacyte Inc (NASDAQ: HUMA) nearly doubled on Friday after receiving full approval for its flagship SYMVESS product…
Bloomberg reports Nike Inc. is bracing for a turbulent phase as new Chief Executive Officer Elliott Hill leads efforts…
Professional investors have long held significant advantages over individual investors. They have vast resources at their disposal, including technology,…
GameStop (GME) stock price has moved sideways in the past few months as investors assess its slow business trajectory…
Thwarted expectations of up to 4 rate cuts in 2025 have sent US stocks tumbling down in recent days.…
Indian shares were wobbly at the time of opening on Friday. Nifty and Sensex continued their downward trend for…